Korea Q1 Roundup: Pharma Begins To Feel Impact From Doctors’ Walkout
Mainstays Generally Strong
As South Korea's doctors continue their long-running protest against a government plan to raise the medical student quota at universities, the walk-outs may be beginning to take a toll on the pharma industry, with many large firms reporting weak earnings in the last quarter.
